Aquabounty Technologies Inc (AQB) Stock Price & Analysis
Aquabounty Technologies Inc (AQB) fell 4.96% to USD 0.91 as of July 25, 2026 at 08:04 UTC, according to Nexqual real-time market data.
AQB last closed at USD 0.96; the session ranged USD 0.88–0.94 on volume of 20,776 shares. Market capitalization is $4.68M, with a 52-week range of USD 0.7–2.95 (NCM). Source: Nexqual, July 25, 2026 at 08:04 UTC.
Key Statistics (as of July 25, 2026 at 08:04 UTC)
| Price | USD 0.91 |
|---|---|
| Change | ▼ 4.96% (down) |
| Previous Close | USD 0.96 |
| Open | USD 0.93 |
| Day Range | USD 0.88 – 0.94 |
| 52-Week Range | USD 0.7 – 2.95 |
| Volume | 20,776 shares |
| Market Cap | $4.68M |
| Exchange | NCM |
Technical Analysis (AQB)
Nexqual's technical model rates AQB "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 08:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.98 (neutral) |
| vs SMA50 | Below (USD 0.99) |
| MACD | -0.02 (negative) |
Analyst Ratings (AQB)
Wall Street analysts rate AQB "None", per Nexqual as of July 25, 2026 at 08:04 UTC.
| Consensus Rating | None |
|---|
Earnings (AQB)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2024-09-30 | USD -0.88 vs est -0.88 ▲ beat |
| 2024-06-30 | USD -1.57 vs est -1.37 ▼ miss |
| 2024-03-31 | USD -1.79 vs est -1.52 ▼ miss |
| 2023-12-31 | USD -2.19 vs est -1.53 ▼ miss |
Source: Nexqual, July 25, 2026 at 08:04 UTC.
Financials & Fundamentals (AQB)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -53.79% |
| Current Ratio | 1.19 |
| Total Cash | $440,678 |
| Total Debt | $3.80M |
| Free Cash Flow | $-9.64M |
Source: Nexqual, July 25, 2026 at 08:04 UTC.
Financial Health Score (AQB)
Nexqual rates Aquabounty Technologies Inc's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 08:04 UTC.
| Growth | Critical — Revenue -21% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Mixed — $441K cash vs $4M debt |
| Cash Flow | Weak — FCF negative: -$10M, burning cash |
| Efficiency | Critical — ROE -54%, ROA -10.9% |
Ownership (AQB)
| Insider Ownership | +0.52% |
|---|---|
| Institutional Ownership | +9.46% |
| Shares Outstanding | 5.15M |
| Float | 5.12M |
| Short % of Float | +1.66% |
Source: Nexqual, July 25, 2026 at 08:04 UTC.
Leadership (AQB)
Aquabounty Technologies Inc is led by David A. Frank (age 65), CFO, Treasurer & Interim CEO, per Nexqual as of July 25, 2026 at 08:04 UTC.
| CFO, Treasurer & Interim CEO | David A. Frank (age 65) |
|---|
Major Backers & Investors (AQB)
Notable institutional backers of Aquabounty Technologies Inc include Renaissance Technologies, Two Sigma Investments, LP, EPIQ Partners, LLC, according to Nexqual as of July 25, 2026 at 08:04 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 2.22% |
| Two Sigma Investments, LP | 1.8% |
| EPIQ Partners, LLC | 1.73% |
| Fidelity | 1.01% |
| Citadel | 0.66% |
| Susquehanna International Group, LLP | 0.23% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.11% |
| Geode Capital | 1.09% |
| BlackRock | 0.92% |
Source: Nexqual, July 25, 2026 at 08:04 UTC.
From Aquabounty Technologies Inc's Latest SEC 10-K Filing (filed 2026-03-31)
Key Strengths & Strategy (as disclosed to the SEC)
- AquaBounty Technologies, Inc. operates as a land-based aquaculture company.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| EVGN | Evogene Ltd. | USD 0.54 | ▲ 0.46% |
| FRSX | Foresight Autonomous Holdings L | USD 1.35 | ▼ 5.45% |
| NNDM | Nano Dimension Ltd. | USD 1.47 | ▼ 0.68% |
| AQMS | Aqua Metals, Inc. | USD 2.71 | ▼ 0.73% |
| PACB | Pacific Biosciences of Californ | USD 1.36 | ▼ 1.45% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 08:04 UTC. This page is informational and not investment advice.